Bausch Health Companies Bhc Q2 2018 Earnings Conference Call Transcript | Latest News RSS feed

Bausch Health Companies Bhc Q2 2018 Earnings Conference Call Transcript - Latest News


Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at Cantor Global Healthcare Conference 2018 (Transcript)

Bausch Health Companies Inc. (NYSE:BHC) Company Conference Presentation October 1, 2018 3:30 PM ET Executives ... what I said in the call and maybe a little bit more since I have learned more since ... read more

EYEPOINT PHARMACEUTICALS INC (EYPT) Q2 2019 Earnings Conference Call Transcript

My name is Amanda, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharma's Fiscal Period Ended December 31st, 2018 Financial Results ... read more

Bausch Health (BHC) Q2 Earnings and Revenues Surpass Estimates

Bausch Health (BHC) just came out with quarterly earnings ... company has surpassed consensus EPS estimates three times. Bausch, which belongs to the Zacks Medical - Generic Drugs industry, posted ... read more

Looking for another news?


Bausch Health (BHC) STOCK BHC STOCK

Bausch Health Cos. , Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It ... read more


Bausch Health Companies Inc. (BHC) Management Presents at Evercore ISI HealthconX Conference (Transcript)

Bausch Health Companies Inc. (NYSE:BHC) Evercore ISI HealthconX Conference Call November 28, 2018 3:30 PM ET Executives Paul Herendeen ... we expect revenue to go back to a level similar to what we ... read more

Bausch Health Companies Inc Total Expenses (TTM)

A company's expenses are how much a company is spending before its net income. This is a useful metric to compare a company spending habits over time. Starting from the income statement, a company may ... read more

PDL BioPharma Inc. (PDLI) Q4 2018 Earnings Conference Call Transcript

Welcome to the PDL BioPharma Quarterly Conference Call ... Bausch Health adding an authorized generic of Glumetza. Additional decreases include the decline in royalties from the Queen et al. patents ... read more

Bausch + Lomb Reports 510(K) Clearance For Ultra Multifocal Lens

(RTTNews) - Bausch + Lomb, a subsidiary of Bausch Health Companies Inc. (BHC), announced that it has received 510(k) clearance from the U.S. FDA for Bausch + Lomb ULTRA Multifocal for Astigmatism ... read more

Bausch Health Companies Inc Revenue (Quarterly YoY Growth)

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are ... read more

EYEPOINT PHARMACEUTICALS INC (EYPT) Q2 2019 Earnings Conference Call Transcript

EYEPOINT PHARMACEUTICALS INC (NASDAQ: EYPT) Q2 2019 Earnings Conference Call March 14 ... thank you for joining us. 2018 was a transformative year for EyePoint Pharmaceuticals as we transitioned from ... read more

PDL BioPharma Inc. (PDLI) Q4 2018 Earnings Conference Call Transcript

PDL BioPharma Inc. (NASDAQ: PDLI) Q4 2018 Earnings Conference Call March 14, 2019 ... it included some one-time gains and an increase in the fair value associated with Bausch Health adding an ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us